Evaluation the role of melatonin in thalassemia patients
Journal of Wahj Al-Ulom for Pure Sciences · 03.07.2026 · 2 (6) · 41-46
DOI: 10.33899/frecac94 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Wahj Al-Ulom for Pure Sciences, online erschienen am 03.07.2026. Verfasst von Lelas Bdaiwi und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This study aimed to evaluate selected biochemical and hematological parameters in serum of thalassemia patients for both sexes, with a comparison to healthy controls. A total of 46 blood samples were collected from Al-Hadba Hospital in Mosul City. The analysis included serum melatonin measurement, along with hemoglobin (Hb), white blood cell (WBC) count, and platelet (PLT) count. The results showed a statistically significant high in hemoglobin levels and melatonin concentration in thalassemia patients compared to healthy individuals. Significant variations in WBC and PLT counts were also observed, as well as differences related to age and sex across the studied groups. The study conclude a significant increase in melatonin levels in thalassemia patients. These results highlight the protective role of melatonin in combating the oxidative damage associated with thalassemia and suggest its potential use as a therapeutic aid to improve patients' quality of life.
Zitieren
APA
Bdaiwi, L., & Algreera, M. (2026). Evaluation the role of melatonin in thalassemia patients. Journal of Wahj Al-Ulom for Pure Sciences, 2(6), 41-46. https://doi.org/10.33899/frecac94
Vancouver
Bdaiwi L, Algreera M. Evaluation the role of melatonin in thalassemia patients. Journal of Wahj Al-Ulom for Pure Sciences. 2026;2(6):41-46. doi:10.33899/frecac94
BibTeX
@article{Bdaiwi2026,
author = {Bdaiwi, Lelas and Algreera, Maysam},
title = {Evaluation the role of melatonin in thalassemia patients},
journal = {Journal of Wahj Al-Ulom for Pure Sciences},
year = {2026},
volume = {2},
number = {6},
pages = {41--46},
doi = {10.33899/frecac94}
}
EUVIMED